Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186563 · ClinicalTrials.gov registry record · NA
A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers
A NA study, sponsored by Martin Angst.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00186563 is a NA study that has completed, run by Martin Angst. The registered enrollment target is 13 participants.
The verdict
NCT00186563, a NA study, has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study aims to establish a novel approach assisting the rational development of analgesic and anti-inflammatory drugs. In a first step we will test in healthy human volunteers whether proteins mediating inflammation and pain can be detected in an experimentally induced inflammatory skin lesion. Fluids that will be used to detect such proteins will be collected from the inflamed skin site via small porous catheters. We wish to establish the expression pattern of different proteins and correlate it with various tests assessing pain.
Interventions
- PROCEDURE Micro-plasmapheresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00186563
The ClinicalTrials.gov registry entry for NCT00186563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Martin Angst, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Micro-plasmapheresis is the first listed.
NCT00186563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00186563 about?
NCT00186563 is a clinical study titled "A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers". This study aims to establish a novel approach assisting the rational development of analgesic and anti-inflammatory drugs. In a first step we will test in healthy human volunteers whether proteins mediating inflammation and pain can be detected in an experimentally induced inflammatory skin lesion. ...
What is the current status of trial NCT00186563?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants.
What interventions are being tested in trial NCT00186563?
The interventions under investigation include: Micro-plasmapheresis (PROCEDURE).
Who is sponsoring clinical trial NCT00186563?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.